Related Experiment Video
Updated: Feb 12, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Sample size calculations for comparative clinical trials with over-dispersed Poisson process data.
1Department of Pharmacoepidemiology, School of Public Health, Kyoto University, Kyoto 606-8501, Japan. matsui@pbh.med.kyoto-u.ac.jp
This study introduces a new sample size formula for clinical trials using Poisson data. It accounts for complex factors like time and patient variations, improving trial design accuracy.
Area of Science:
- Biostatistics
- Clinical Trial Design
- Epidemiology
Background:
- Accurate sample size calculation is crucial for the validity and efficiency of comparative clinical trials.
- Traditional methods may not adequately address the complexities of Poisson or over-dispersed Poisson process data.
- Heterogeneity in event rates and time-varying effects present challenges in sample size determination.
Purpose of the Study:
- To develop and present a novel formula for sample size calculations in comparative clinical trials.
- To specifically address trials involving Poisson or over-dispersed Poisson process data.
- To create a formula that accommodates time heterogeneity, inter-patient heterogeneity, and time-varying treatment effects.
Main Methods:
- Development of a new sample size formula based on asymptotic approximations.
- Utilized a two-sample non-parametric test to compare empirical event rate functions between treatment groups.
- The formula's capability to incorporate various sources of heterogeneity and time-dependent effects was established.
Main Results:
- A new, versatile formula for sample size calculations in relevant clinical trials has been successfully developed.
- The formula demonstrates the ability to account for time heterogeneity, inter-patient variability, and time-varying treatment effects.
- An illustrative application to a chronic granulomatous disease trial is provided, demonstrating practical utility.
Conclusions:
- The proposed formula offers a more robust approach to sample size calculation for comparative clinical trials with complex event rate data.
- This methodology enhances the precision of sample size determination, leading to more reliable trial outcomes.
- The formula's applicability is demonstrated, suggesting its value for future clinical trial planning and statistical analysis.
More Related Videos
05:16Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
Published on: May 7, 2020
14:45Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
Published on: September 16, 2012
Related Concept Videos
Sample Size Calculation
The sample size for the given experiment or sampling effort is fundamental to any study design. Sample size decides the number of...
Statistical Software for Data Analysis and Clinical Trials
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
One-Way ANOVA: Unequal Sample Sizes
One-Way ANOVA: Equal Sample Sizes
Different sample means can result in different values for the variance estimate: variance between samples. This is because the variance between samples is calculated as the product of the sample size and the variance between the...